Ⅲ型纤连蛋白组件包含蛋白5通过抑制ERK1/2磷酸化抑制C3H10T1/2细胞成脂分化

旨在探究Ⅲ型纤连蛋白组件包含蛋白5(type Ⅲ domain-containing protein5,FNDC5)对C3H10T1/2细胞成脂分化的调控作用.利用qRT-PCR和Western印迹检测FNDC5在C3H10T1/2细胞成脂分化过程中的时序性表达规律;构建慢病毒包被的过表达/干扰FNDC5载体,转染C3...     

BMP2具有诱导C3H10T1/2细胞成脂肪分化的能力

探讨骨形态发生蛋白2（BMP2）诱导鼠胚胎间充质干细胞C3H10T1/2成脂肪分化能力,为临床脂肪代谢疾病的治疗提供理论基础．培养多潜能的间充质干细胞C3H10T1/2,用20 μg/ml BMP2对其诱导一定时间后,RT-PCR检测是否存在BMP信号通路中关键分子BMP受体BMPR I, BMPR Ⅱ及Smad 1/5/8的表达.Western印迹检测Smad 蛋白及MAPK 信号通路中p38磷酸化水平变化,QRT PCR检测成脂肪标志基因aP2以及成脂肪相关转录因子PPARγ,C/EBPα,C/EBPβ表达水平,同时用油红O染色,观测C3H10T1/2细胞成脂肪分化情况．经BMP2诱导后,C3H10T1/2细胞成脂肪分化标志(油红O染色)显著增加,Smad 蛋白及p38磷酸化水平有所上升,同时成脂肪标志基因aP2以及成脂肪相关转录因子PPARγ,C/EBPα,C/EBPβ表达水平各有一定程度提高．BMP2具有诱导C3H10T1/2细胞成脂肪分化能力,其成脂肪分化呈现对BMP2作用的时间依赖性．     

孤儿核受体SHP敲减抑制BMP9诱导C3H10T1/2细胞的成骨分化

孤儿核受体SHP(small heterodimer partner)是核受体超家族中的一员,具有LXXLL模体及配体结合域,但无经典的DNA结合域.它可与多种转录因子结合,调节细胞的增殖、分化和代谢等生物学过程.但目前关于SHP在BMP9诱导成骨分化中的确切作用却尚不清楚.本研究证明,SHP参与BMP9诱导的C3H10T1/2细胞成骨分化. RT-PCR结合Western印迹方法检测蛋白揭示,异位表达BMP9上调了SHP在C3H10T1/2细胞中的表达. 小干扰RNA敲减SHP基因在C3H10T1/2细胞的表达下调了成骨相关基因Runx2、Id1、Id2及CTGF的表达,而过表达BMP9则可上调这些基因的表达.碱性磷酸酶(ALP)活性测定/染色及茜素红染色显示,敲减核受体SHP基因可抑制BMP9的成骨分化作用,而过表达BMP9可部分消除SHP 敲减导致的成骨抑制作用.上述结果提示,核受体SHP为BMP9诱导的C3H10T1/2细胞成骨分化所必需. 究竟BMP9如何上调SHP基因表达,以及SHP究竟通过何种机制上调BMP9下游成骨分化相关基因的表达尚待进一步研究.     

MiR-21协同BMP9促进间充质干细胞C3H10T1/2成骨分化

目的:探讨miR-21与BMP9之间的关系,明确miR-21在BMP9诱导间充质干细胞成骨分化中的作用。方法:(1)Ad-BMP9感染C3H10T1/2细胞,Real-time-PCR检测miR-21表达。RT-PCR检测ALP的表达。(2)MiR-21转染C3H10T1/2细胞,Real-time-PCR检测miR-21和BMP9表达。(3)MiR-21和BMP9-CM处理C3H10 T1/2细胞,ALP活性和染色实验检测C3H10 T1/2细胞早期成骨能力。茜素红S染色实验检测钙盐沉积情况。(4)MiR-21和BMP9-CM处理C3H10 T1/2细胞,Real-time-PCR检测成骨分化相关因子ALP,OCN的表达。(5)MiR-21和BMP9-CM处理C3H10T1/2细胞,Western blot检测p-Smad1/5蛋白水平的表达。结果:(1)BMP9暂时降低miR-21的表达。MiR-21也可以暂时降低BMP9的表达。(2)MiR-21可以协同BMP9增强ALP和钙盐沉积。(3)MiR-21协同BMP9增加了p-Smad1/5蛋白水平的表达。结论:MiR-21与BMP9存在相互关系,两者可以互相调节表达。MiR-21可以协同BMP9促进间充质干细胞C3H10T1/2细胞成骨分化,这一过程与增强BMP9/Smad信号的激活程度有关。     

过表达miR-155抑制BMP9诱导间充质干细胞C3H10T1/2成骨分化

目的:研究过表达miR-155对BMP9诱导间充质干细胞C3H10T1/2成骨分化的影响。方法:(1)用重组腺病毒Ad-BMP9(BMP9)诱导C3H10T1/2细胞成骨分化,定量PCR(qPCR)检测miR-155的表达,RT-PCR检测Runx2和ALP的表达。(2)miR-155和BMP9共同处理C3H10T1/2细胞,qPCR检测miR-155的表达,ALP活性和染色检测早期成骨能力。(3)miR-155和BMP9共同处理C3H10T1/2细胞,诱导分化14d茜素红S染色检测晚期成骨能力。(4)miR-155和BMP9共同处理C3H10T1/2细胞,qPCR检测成骨分化相关基因Runx2、OSX、COL1A1、ALP、OCN和OPN的表达。(5)miR-155和BMP9共同处理C3H10T1/2细胞,Western blot检测p-Smad1/5/8、OCN和OPN蛋白水平的表达。(6)qPCR和Western blot分别检测HIF1α和VEGF的mRNA表达水平和蛋白质表达水平。(7)应用荧光素酶报告基因对miR-155的靶基因进行筛选和验证。结果:在BMP9诱导C3H10T1/2细胞成骨分化过程中,过表达miR-155降低ALP活性及染色;减少钙盐沉积;成骨分化相关基因Runx2、OSX、COL1A1、ALP、OCN和OPN表达降低;抑制p-Smad1/5/8、OCN和OPN蛋白水平的表达;HIF1α和VEGF的mRNA和蛋白表达水平减少。在对靶基因的检测中,过表达miR-155可以抑制HIF1α蛋白水平的表达,但对其mRNA水平无明显影响。结论:miR-155过表达减弱BMP9诱导间充质干细胞C3H10T1/2成骨分化,可能是通过抑制Smad/BMP信号通路发挥作用,也有可能是通过抑制靶基因HIF1α的表达来发挥作用。     

MYOZ2通过负调控TCAP的表达促进C3H10T1/2细胞成脂分化

本研究旨在明确钙调磷酸酶肌小节结合蛋白2(myozenin2,MYOZ2)的组织表达特性,阐明其对C3H10T1/2细胞成脂分化的影响及可能的作用机制.采集180日龄马身猪、60日龄ICR小鼠、35日龄罗斯肉鸡和12月龄小尾寒羊背最长肌、皮下脂肪和肝组织,检测MYOZ2基因mRNA表达.结果 显示,MYOZ2基因在所检...     

Hmox1促进BMP9诱导C3H10T1/2细胞向成骨分化

目的:研究血红素加氧酶1(hemeoxygenase 1,Hmox1)在骨形态发生蛋白9(bone morphogenetic proteins 9,BMP9)诱导下间充质干细胞C3H10T1/2向成骨分化过程中发挥的作用。方法:用Ad-BMP9感染C3H10T1/2,分别用Q-PCR和Western blot检测Hmox1mRNA和蛋白水平的变化;Hmox1激动剂COPP处理BMP9诱导的C3H10T1/2细胞,碱性磷酸酶(ALP)染色和活性测定检测早期成骨指标ALP的变化;过表达Hmox1的重组腺病毒(Ad-Hmox1)处理BMP9诱导的C3H10T1/2细胞,ALP染色和活性测定早期成骨指标ALP,茜素红染色检测晚期成骨指标钙盐沉积,Western blot检测成骨相关基因COL1A1。结果:Ad-BMP9感染C3H10T1/2后,Hmox1的mRNA及蛋白水平均升高;BMP9与Hmox1激动剂COPP联用与BMP9组相比ALP的活性增强;Ad-Hmox1可以增强BMP9诱导下C3H10T1/2细胞的ALP活性和钙盐沉积,以及成骨相关基因COL1A1表达。结论:Hmox1可以促进BMP9诱导下C3H10T1/2细胞的成骨分化。     

Hey1基因参与调控BMP9诱导的C3H10T1/2细胞成骨分化

目的:观察发状分裂相关增强子Hey1在骨形态发生蛋白9(BMP9)诱导的小鼠间充质干细胞(MSCs)C3H10T1/2成骨分化中的作用。方法:包装Hey1、BMP9以及GFP的过表达慢病毒,并分别作用于C3H10T1/2细胞,RT-PCR和Western blot检测Hey1、BMP9以及GFP的慢病毒是否包装成功,碱性磷酸酶(ALP)检测早期成骨指标ALP的变化,茜素红S染色检测晚期成骨指标钙盐沉积,MTT检测Hey1对BMP9调控的C3H10T1/2细胞增值的影响,流式细胞术检测Hey1对BMP9调控的C3H10T1/2细胞周期的影响。结果:Hey1、BMP9以及GFP的慢病毒包装成功;在成骨分化早期,过表达Hey1基因可促进BMP9调控的C3H10T1/2细胞的成骨分化与增殖;在成骨分化晚期,过表达Hey1基因可促进BMP9诱导的C3H10T1/2细胞的成骨分化,并将BMP9调控的C3H10T1/2细胞周期阻滞在G1期。结论:Hey1基因可参与调控BMP9诱导的小鼠C3H10T1/2细胞的早晚期成骨分化,并对细胞的增殖与周期有一定的影响。     

SAHA抑制间充质干细胞C3H10T1/2的增殖与成脂分化

本文研究组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸（suberoylanilide hydroxamic acid,SAHA）对间充质干细胞(mesenchymal stem cells, MSCs) C3H10T1/2增殖和成脂分化的影响及其可能的作用机制.用Western印迹验证SAHA对细胞内蛋白乙酰化的影响;用MTT和流式细胞术检测细胞活性和细胞周期;利用油红O染色检测细胞成脂分化,实时定量PCR检测PPARγ2和成脂分化标志物Fabp4、perilipin以及adipoq mRNA的转录.Western印迹结果显示,SAHA可促进细胞内蛋白的乙酰化.MTT和流式细胞术结果显示,SAHA对C3H10T1/2细胞活性的抑制呈浓度依赖性,随着SAHA浓度增加,细胞形态趋向于展平,并将细胞周期抑制在G0/G1期;SAHA可呈浓度依赖性抑制C3H10T1/2 细胞的成脂分化作用.同时实时定量PCR结果显示,SAHA抑制成脂关键转录因子PPARγ2,脂肪因子Fabp4、perilipin和adipoq mRNA的转录.综上所述,SAHA可影响间充质干细胞C3H10T1/2细胞形态,并呈剂量依赖性地抑制其增殖和成脂分化.     

BMP-2 treatment of C3H10T1/2 mesenchymal cells blocks MMP-9 activity during chondrocyte commitment

Members of both the Wnt and bone morphogenetic protein (BMP) families of signaling molecules have been implicated in the regulation of cartilage development. We explored the underlying mechanism of BMP-2-induced chondrocyte commitment of C3H10T1/2 cells. Treating cells with exogenous BMP-2 was tied to chondrocyte commitment by inhibiting matrix metalloproteinase-9 activity (MMP-9: 92 kDa type IV collagenase/gelatinase B). Glycogen synthase kinase (GSK)-3β inhibition by its specific inhibitor blocked BMP-2-induced chondrocyte commitment by stimulating MMP-9 activity. These findings indicate that the downregulation of MMP-9 by BMP-2 is associated with chondrocyte commitment, and that the GSK-3β signaling pathway is involved in this process.     

Galactosylceramide expression factor-1 induces myogenesis in MDCK and C3H10T1/2 cells

We previously reported that galactosylceramide expression factor-1 (GEF-1), a rat homolog of hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs/Hgs), induces galactosylceramide and/or sulfatide expression and morphological changes in epithelial cells. Here, we show that GEF-1 induces myogenesis in MDCK and C3H10T1/2 cells. GEF-1 overexpression in MDCK cells (MDCK/GEF-1) appeared to promote trans-differentiation to myoblasts that expressed MyoD and myosin heavy chain (MHC). MDCK/GEF-1 cells also expressed several DNA-binding proteins (MyoD and MEF-2) that are essential for myogenesis. These results suggest that GEF-1 induces MDCK cells to enter an early stage of myogenesis. Subsequently, we tested whether GEF-1 could induce myogenesis in C3H10T1/2 mouse fibroblasts, which have the potential to differentiate into myoblast-like cells. Indeed, GEF-1 induced morphological changes that were consistent with myoblast-like cells, and both MyoD and MHC were expressed. Our results suggest that GEF-1 may induce MDCK and C3H10T1/2 cells to trans-differentiate into myoblast-like cells.